Format

Send to

Choose Destination
Zhonghua Nan Ke Xue. 2017 Jul;23(7):656-662.

[Prevention and treatment of erectile dysfunction after prostatectomy: An update].

[Article in Chinese; Abstract available in Chinese from the publisher]

Author information

1
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Abstract

in English, Chinese

Prostate cancer has the highest incidence among malignant tumors of the urinary system in China. Radical prostatectomy (RP) is the most effective treatment for localized prostate cancer with a good long-term prognosis. Erectile dysfunction (ED) is a common complication after RP, which seriously affects the patient's quality of life. With the rising incidence and early diagnosis of prostate cancer, the proportion of young cases of RP is increasing, and so is the importance of the treatment of post-RP ED. The restoration of erectile function after RP is closely related to the timing of penile rehabilitation as well as to pre- and intra-operative measures such as surgical strategies and methods. Common options for the treatment of post-RP ED include oral medication of phosphodiesterase type 5 inhibitors, application of vasoactive substances in the urethra or corpus cavernosum, use of vacuum erection devices, and implantation of penile prosthesis. Stem cell therapy, nerve transplantation, low-intensity extracorporeal shockwave therapy, and erythropoietin have shown great potential in penile rehabilitation after RP. At present, the stress is placed on the remission of symptoms in the treatment of ED. Stem cell therapy may reverse the cause of disease or cure ED by reversing its pathophysiological changes. A series of clinical trials of stem cell therapy are underway and have preliminarily confirmed the safety of stem cell therapy and proved that it can improve erectile function in patients with post-RP ED. This review focuses on the progress in the prevention and treatment of ED after RP.

KEYWORDS:

erectile dysfunction; erythropoietin; low-intensity extracorporeal shockwave; nerve graft; penile rehabilitation; stem cell ; radical prostatectomy

PMID:
29723462
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center